Acasti Pharma Inc.

07/27/2022 | Press release | Distributed by Public on 07/27/2022 06:04

Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia